Avanos Medical, Inc. (AVNS) — Financial statements
Income statement, balance sheet, and cash flow for Avanos Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 701↑1.9% | 688↑2.2% | 673↓1.6% | 684↓8.1% | 745 | |
| Cost of Revenue | 352↑14.9% | 307↑4.4% | 294↑1.3% | 290↓20.5% | 365 | |
| Gross Profit | 349↓8.5% | 381↑0.4% | 380↓3.7% | 394↑3.8% | 380 | |
| Operating Expenses | ||||||
| R&D Expenses | 23↓11.8% | 26↓3.7% | 27↓11.1% | 31↓5.3% | 32 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 218↓30.7% | 315↑9.6% | 288↓11.0% | 323↑23.9% | 261 | |
| Other Expenses | 169 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 411↑20.3% | 341↑8.5% | 315↓10.7% | 352↑20.2% | 293 | |
| Total Costs & Expenses | 763↑17.8% | 648↑6.5% | 608↓5.3% | 642↓2.4% | 658 | |
| Operating Results | ||||||
| Operating Income | -62↓254.0% | 40↓38.5% | 65↑55.1% | 42↓51.7% | 87 | |
| Depreciation & Amortization | 29↓36.3% | 46↑4.6% | 44↑5.8% | 41↑7.3% | 38 | |
| EBITDA | -33↑90.4% | -346↓783.0% | 51↓35.0% | 78↑59.1% | 49 | |
| EBIT | -62↑84.1% | -391↓5608.5% | 7↓80.7% | 37↑246.2% | 11 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.80↑88.7% | -7↑41.3% | -12↓37.5% | -9↓183.9% | -3 | |
| Interest Income | 3↓37.3% | 5↑75.9% | 3↑141.7% | 1↑500.0% | 0.20 | |
| Interest Expense | 4↓67.2% | 12↓18.7% | 15↑50.0% | 10↑203.0% | 3 | |
| Non-Operating Income | 0.60↓99.9% | 431↑644.6% | 58↑1013.5% | 5↓93.2% | 76 | |
| Other Income / Expenses | -5↑99.0% | -443↓508.1% | -73↓379.6% | -15↑80.9% | -80 | |
| Income Before Tax | -66↑83.6% | -403↓5005.1% | -8↓129.6% | 27↑265.8% | 7 | |
| Income Tax Expense | 2↑110.0% | -17↓950.0% | 2↓61.5% | 5↑420.0% | 1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -68↑82.4% | -386↓3802.0% | -10↓146.0% | 22↑241.3% | 6 | |
| Net Income from Discontinued Operations | 0.00↑100.0% | -6↑88.8% | -52↓279.0% | 29 | 0.00 | |
| Net Income | -68↑82.7% | -392↓534.5% | -62↓222.4% | 51↑701.6% | 6 | |
| Bottom-Line Net Income | -68↑82.7% | -392↓534.5% | -62↓222.4% | 51↑701.6% | 6 | |
| EPS (Basic) | -1.46↑82.9% | -8.53↓541.4% | -1.33↓223.1% | 1.08↑730.8% | 0.13 | |
| EPS (Diluted) | -1.46↑82.9% | -8.53↓541.4% | -1.33↓224.3% | 1.07↑723.1% | 0.13 | |
| Weighted Average Shares | 46↑0.9% | 46↓1.3% | 47↓0.6% | 47↓2.5% | 48 | |
| Weighted Average Diluted Shares | 46↑0.9% | 46↓1.3% | 47↓1.5% | 47↓2.7% | 49 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.